What investor type does iShares MSCI Emerging Markets ex China ETF fit best in FoxScore?

iShares MSCI Emerging Markets ex China ETF fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.

How meaningful is the available history for iShares MSCI Emerging Markets ex China ETF?

iShares MSCI Emerging Markets ex China ETF currently has about 8.6 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.

What is FoxScore good for — and what is it not for?

FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.

Analysis for iShares MSCI Emerging Markets ex China ETF

EMXC · As of: 02/17/2026

Basic information

Type: ETF

Region: US

Sector: Diversified

TER: 0.3 %

History

Available history:8.6 years

Last tradingday:02/17/2026

Description & usage

The iShares MSCI Emerging Markets ex China ETF provides equity exposure to emerging markets while intentionally excluding China. This gives access to many EM countries (such as Taiwan, India, Brazil or South Africa, depending on index composition) without China-specific policy and regulatory exposure. Returns are driven by EM growth, commodity and trade cycles, and currency movements. Emerging-market equities can be volatile. The ETF is used to express emerging-markets exposure specifically “without China.”

Scale: 0 = weak, 50 = average, 100 = top

Analysis summary

iShares MSCI Emerging Markets ex China ETF (EMXC) currently has a total score of 72 points, placing it in the strong range. The score is made up of Performance (60), Stability (87) and Trend (80). All three sub-scores are currently above average.

Performance scores 60 points (strong). Key strength: 1Y return at 45.9 %. Even the weakest return is still strong in absolute terms: 5Y return at 38.3 %. This points to a sharper upswing more recently.

Stability scores 87 points (very strong). Key strength: Sharpe ratio (90d) at 2.20. Main drag: CAGR/drawdown ratio at 0.22. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.

Trend scores 80 points (very strong). Key strength: Price is about 22.7 % above SMA200. Even the weakest metric remains solid in absolute terms: trend strength at 0.86.

Overall, the profile has a clear strength in Stability, while Performance is the main limiter. On a metric level, Sharpe ratio (90d) stands out, while 5Y return lags.

(Historical evaluation, not investment advice.)

Chart anzeigen

Wenn du fortfährst, wird der Chart von TradingView geladen. Dabei können Daten (z. B. deine IP-Adresse) an TradingView übertragen werden.

Overall score

strong

Scores

Metrics

FAQ

What investor type does iShares MSCI Emerging Markets ex China ETF fit best in FoxScore?: iShares MSCI Emerging Markets ex China ETF fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
How meaningful is the available history for iShares MSCI Emerging Markets ex China ETF?: iShares MSCI Emerging Markets ex China ETF currently has about 8.6 years of price history since it started trading. That’s a solid base to interpret returns, drawdowns and trend behavior since launch — earlier market crises happened before the asset existed and are therefore not part of its history.
What is FoxScore good for — and what is it not for?: FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.